UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN C000000065
Receipt number R000000106
Scientific Title Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
Date of disclosure of the study information 2005/08/17
Last modified on 2008/12/17 23:07:45

No. Disposal Last modified on Item of update
1 Insert 2005/08/17 18:27:19
2 Update 2005/08/17 20:03:30 Public title
Public title
Acronym
Acronym
3 Update 2006/03/14 12:22:52 URL related to results and publications
Results
Results
4 Update 2006/03/30 16:46:35 URL related to results and publications
5 Update 2007/06/22 00:00:48 Publication of results
Results
Results
6 Update 2008/07/04 01:02:56 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2008/12/17 23:07:45 Division name
Division name
Last name of contact person
Last name of contact person
Division name
Division name
TEL
Email
Name of person sending information
Name of person sending information
Division name
Division name
TEL
Email